Limits...
Cost-effectiveness of multidisciplinary management of Tinnitus at a specialized Tinnitus centre.

Cima R, Joore M, Maes I, Scheyen D, Refaie AE, Baguley DM, Vlaeyen JW, Anteunis L - BMC Health Serv Res (2009)

Bottom Line: As a result of the tinnitus, quality of life is often impaired.At present there is no cure or uniformly effective treatment, leading to fragmentized and costly tinnitus care.Evidence suggests that a comprehensive multidisciplinary approach in treating tinnitus is effective.

View Article: PubMed Central - HTML - PubMed

Affiliation: Clinical Psychological Science, Maastricht University, Maastricht, The Netherlands. r.cima@dmkep.unimaas.nl

ABSTRACT

Background: Tinnitus is a common chronic health condition that affects 10% to 20% of the general population. Among severe sufferers it causes disability in various areas. As a result of the tinnitus, quality of life is often impaired. At present there is no cure or uniformly effective treatment, leading to fragmentized and costly tinnitus care. Evidence suggests that a comprehensive multidisciplinary approach in treating tinnitus is effective. The main objective of this study is to examine the effectiveness, costs, and cost-effectiveness of a comprehensive treatment provided by a specialized tinnitus center versus usual care. This paper describes the study protocol.

Methods/design: In a randomized controlled clinical trial 198 tinnitus patients will be randomly assigned to a specialized tinnitus care group or a usual care group. Adult tinnitus sufferers referred to the audiological centre are eligible. Included patients will be followed for 12 months. Primary outcome measure is generic quality of life (measured with the Health Utilities Index Mark III). Secondary outcomes are severity of tinnitus, general distress, tinnitus cognitions, tinnitus specific fear, and costs. Based on health state utility outcome data the number of patients to include is 198. Economic evaluation will be performed from a societal perspective.

Discussion: This is, to our knowledge, the first randomized controlled trial that evaluates a comprehensive treatment of tinnitus and includes a full economic evaluation from a societal perspective. If this intervention proves to be effective and cost-effective, implementation of this intervention is considered and anticipated.

Trial registration: The trial has been registered at ClinicalTrial.gov. The trial registration number is NCT00733044.

Show MeSH

Related in: MedlinePlus

Flowchart levels of care within randomized controlled clinical trial in Tinnitus Centre Limburg.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC2654550&req=5

Figure 1: Flowchart levels of care within randomized controlled clinical trial in Tinnitus Centre Limburg.

Mentions: A randomised controlled clinical trial will be performed, with 2 conditions (Fig. 1). Patients will be assigned to a Usual Care (UC) Control condition or a Tinnitus Centre Limburg care (TCL) condition. Both treatment conditions (UC and TCL) will be provided by the Audiological Centre Hoensbroeck. Measures will be taken for blinding patients to treatment assignment.


Cost-effectiveness of multidisciplinary management of Tinnitus at a specialized Tinnitus centre.

Cima R, Joore M, Maes I, Scheyen D, Refaie AE, Baguley DM, Vlaeyen JW, Anteunis L - BMC Health Serv Res (2009)

Flowchart levels of care within randomized controlled clinical trial in Tinnitus Centre Limburg.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC2654550&req=5

Figure 1: Flowchart levels of care within randomized controlled clinical trial in Tinnitus Centre Limburg.
Mentions: A randomised controlled clinical trial will be performed, with 2 conditions (Fig. 1). Patients will be assigned to a Usual Care (UC) Control condition or a Tinnitus Centre Limburg care (TCL) condition. Both treatment conditions (UC and TCL) will be provided by the Audiological Centre Hoensbroeck. Measures will be taken for blinding patients to treatment assignment.

Bottom Line: As a result of the tinnitus, quality of life is often impaired.At present there is no cure or uniformly effective treatment, leading to fragmentized and costly tinnitus care.Evidence suggests that a comprehensive multidisciplinary approach in treating tinnitus is effective.

View Article: PubMed Central - HTML - PubMed

Affiliation: Clinical Psychological Science, Maastricht University, Maastricht, The Netherlands. r.cima@dmkep.unimaas.nl

ABSTRACT

Background: Tinnitus is a common chronic health condition that affects 10% to 20% of the general population. Among severe sufferers it causes disability in various areas. As a result of the tinnitus, quality of life is often impaired. At present there is no cure or uniformly effective treatment, leading to fragmentized and costly tinnitus care. Evidence suggests that a comprehensive multidisciplinary approach in treating tinnitus is effective. The main objective of this study is to examine the effectiveness, costs, and cost-effectiveness of a comprehensive treatment provided by a specialized tinnitus center versus usual care. This paper describes the study protocol.

Methods/design: In a randomized controlled clinical trial 198 tinnitus patients will be randomly assigned to a specialized tinnitus care group or a usual care group. Adult tinnitus sufferers referred to the audiological centre are eligible. Included patients will be followed for 12 months. Primary outcome measure is generic quality of life (measured with the Health Utilities Index Mark III). Secondary outcomes are severity of tinnitus, general distress, tinnitus cognitions, tinnitus specific fear, and costs. Based on health state utility outcome data the number of patients to include is 198. Economic evaluation will be performed from a societal perspective.

Discussion: This is, to our knowledge, the first randomized controlled trial that evaluates a comprehensive treatment of tinnitus and includes a full economic evaluation from a societal perspective. If this intervention proves to be effective and cost-effective, implementation of this intervention is considered and anticipated.

Trial registration: The trial has been registered at ClinicalTrial.gov. The trial registration number is NCT00733044.

Show MeSH
Related in: MedlinePlus